Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Aimmune Therapeutics, Inc. | d95808dex51.htm |
| S-1MEF - S-1MEF - Aimmune Therapeutics, Inc. | d95808ds1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Aimmune Therapeutics, Inc.:
We consent to the use of our report in the registration statement (No. 333-205501) on Form S-1, included therein and incorporated by reference herein and to the reference to our firm under the heading “Experts”.
/s/ KPMG LLP
San Francisco, California
August 5, 2015